Given investment horizon of 30 days, Generex Biotechnology Corporation is expected to under-perform the Insite. In addition to that, Generex is 1.02 times more volatile than Insite Vision Inc.. It trades about -0.07 of its total potential returns per unit of risk. Insite Vision Inc. is currently generating about -0.01 per unit of volatility. If you would invest 37.00 in Insite Vision Inc. on April 26, 2012 and sell it today you would lose (2.00) from holding Insite Vision Inc. or give up 5.41% of portfolio value over 30 days.
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Generex Biotechnology Corp. and Insite Vision Inc. in the same portfolio (assuming nothing else is changed)